Table 1. Baseline characteristics of patients.
| Patients data | ATD group (n = 114) Mean ± SD | Non ATD group (n = 794) Mean ± SD | P value 2 |
| Age | 72 (64 – 80) | 63 (52 – 74) | < 0.001 1 |
| Male/Female | 76/38 | 439/355 | 0.022 1 |
| BMI (kg/m 2 ) | 21.62 ± 2.84 | 21.82 ± 3.48 | 0.557 |
| Underlying disease 1 | < 0.001 1 | ||
| DM | 38 | 347 | |
| HT | 8 | 81 | |
| DM, HT | 28 | 98 | |
| ESRD without hemodialysis | 4 | 8 | |
| Decompensated Cirrhosis | 1 | 9 | |
| CAD | 21 | 1 | |
| CVA | 4 | – | |
| AF | 4 | – | |
| DVT | 3 | – | |
| PVD | 2 | – | |
| PE | 1 | – | |
| Platelet count (× 10 4 /ul) | 21.87 ± 7.05 | 23.79 ± 12.34 | 0.105 |
| INR | 1.15 ± 0.15 | 1.05 ± 0.09 | 0.007 1 |
| Hemoglobin before FNA (g/dl) | 12.53 ± 1.79 | 13.14 ± 1.72 | 0.001 1 |
| Hemoglobin after FNA (g/dl) | 11.90 ± 1.66 | 12.47 ± 1.68 | 0.001 1 |
| Length of hospital stay | 5.52 ± 7.76 | 4.30 ± 6.98 | 0.088 |
DM, diabetes mellitus; HT, hypertension; CAD, coronary arterial disease; ESRD, End-stage renal disease; CVA, cerebrovascular disease; PE, pulmonary embolism; PVD, peripheral vascular disease; DVT, deep vein thrombosis; Hb, hemoglobin; ATD, antithrombotic drugs; SD, standard deviation; FNA, fine needle aspiration
1
Important underlying disease-related antithrombotic treatment. Some patients had multiple underlying diseases
2
Statistically significant ( P < 0.05)